Barclays’s Aravive, Inc. Common Stock ARAV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,678
| Closed | -$6K | – | 4851 |
|
|
2021
Q3 | $6K | Sell |
1,678
-1,448
| -46% | -$6.18K | ﹤0.01% | 4591 |
|
|
2021
Q2 | $19K | Sell |
3,126
-7,038
| -69% | -$37.2K | ﹤0.01% | 4515 |
|
|
2021
Q1 | $67K | Buy |
10,164
+6,240
| +159% | +$41K | ﹤0.01% | 4136 |
|
|
2020
Q4 | $22K | Sell |
3,924
-1,641
| -29% | -$9.01K | ﹤0.01% | 4664 |
|
|
2020
Q3 | $27K | Sell |
5,565
-1,109
| -17% | -$7.87K | ﹤0.01% | 4840 |
|
|
2020
Q2 | $78K | Buy |
+6,674
| New | +$79.2K | ﹤0.01% | 4681 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | – | – | 6567 |
|
|
2019
Q4 | $0 | Sell |
1
-38
| -97% | -$336 | ﹤0.01% | 6942 |
|
|
2019
Q3 | $0 | Hold |
39
| – | – | ﹤0.01% | 7245 |
|
|
2019
Q2 | $0 | Hold |
39
| – | – | ﹤0.01% | 7374 |
|
|
2019
Q1 | $0 | Hold |
39
| – | – | ﹤0.01% | 7421 |
|
|
2018
Q4 | $0 | Hold |
39
| – | – | ﹤0.01% | 7450 |
|
|
2018
Q3 | $0 | Sell |
39
-7,775
| -100% | -$81.9K | ﹤0.01% | 7473 |
|
|
2018
Q2 | $95K | Buy |
7,814
+6,669
| +582% | +$68.7K | ﹤0.01% | 5286 |
|
|
2018
Q1 | $12K | Sell |
1,145
-779
| -40% | -$8.76K | ﹤0.01% | 6611 |
|
|
2017
Q4 | $26K | Sell |
1,924
-6,535
| -77% | -$84.1K | ﹤0.01% | 6161 |
|
|
2017
Q3 | $125K | Buy |
8,459
+7,940
| +1,530% | +$801K | ﹤0.01% | 4772 |
|
|
2017
Q2 | $54K | Buy |
519
+230
| +80% | +$24.7K | ﹤0.01% | 5315 |
|
|
2017
Q1 | $37K | Sell |
289
-90
| -24% | -$9.49K | ﹤0.01% | 5503 |
|
|
2016
Q4 | $34K | Buy |
379
+307
| +426% | +$23.3K | ﹤0.01% | 5377 |
|
|
2016
Q3 | $5K | Sell |
72
-18
| -20% | -$1.3K | ﹤0.01% | 6034 |
|
|
2016
Q2 | $6K | Buy |
90
+65
| +260% | +$3.69K | ﹤0.01% | 5718 |
|
|
2016
Q1 | $1K | Sell |
25
-52
| -68% | -$2.76K | ﹤0.01% | 6027 |
|
|
2015
Q4 | $7K | Sell |
77
-1,524
| -95% | -$102K | ﹤0.01% | 5501 |
|
|
2015
Q3 | $105K | Buy |
1,601
+1,519
| +1,852% | +$142K | ﹤0.01% | 4596 |
|
|
2015
Q2 | $7K | Sell |
82
-23
| -22% | -$2.33K | ﹤0.01% | 6294 |
|
|
2015
Q1 | $12K | Buy |
105
+11
| +12% | +$1.29K | ﹤0.01% | 6134 |
|
|
2014
Q4 | $12K | Buy |
94
+56
| +147% | +$6.55K | ﹤0.01% | 6636 |
|
|
2014
Q3 | $4K | Buy |
38
+13
| +52% | +$1.72K | ﹤0.01% | 7261 |
|
|
2014
Q2 | $4K | Buy |
+25
| New | +$4.32K | ﹤0.01% | 7216 |
|
Other funds holding ARAV
AG
NLVP
Barclays's ARAV Position: Q4 2021 in Review
Barclays sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2021, closing a stake of 1,678 shares — an estimated $6K sold.
Barclays first reported a position in ARAV in Q2 2014 and held it in 29 quarters. The position peaked at $125K in Q3 2017. 36 funds tracked by Wall St. Rank hold ARAV as of Q4 2021.
- Barclays reported no remaining Aravive, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
- Barclays sold 1,678 Aravive, Inc. Common Stock shares in Q4 2021, an estimated $6K.
- Barclays first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 29 quarters.
- Barclays's Aravive, Inc. Common Stock position peaked at $125K in Q3 2017.
- 36 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2021.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.